ConductScience.org, home

Library / Trials

tDCS as Adjunctive Therapy to Cognitive Stimulation in Medical Students With Depression

NCT06562387, Not applicable, Unknown, Universidad Nacional Autonoma de Mexico

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitletDCS as Adjunctive Therapy to Cognitive Stimulation in Medical Students With DepressionClinicalTrials.gov
NCT numberNCT06562387ClinicalTrials.gov
StatusUnknownClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment60 participants, actualClinicalTrials.gov
Lead sponsorUniversidad Nacional Autonoma de MexicoClinicalTrials.gov
ConditionsClinical TrialClinicalTrials.gov
Interventionstranscranial direct current stimulation, cognitive stimulation, sham transcranial direct current stimulationClinicalTrials.gov
First posted2024-08-20ClinicalTrials.gov
Last updated2024-08-20ClinicalTrials.gov

Registered outcomes 4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryTo compare performance on Cognitive improvement (Montreal Cognitive Assessment) between active and sham tDCS groupsthree months
remain the same or increase by 1 point on the Montreal Cognitive Assessment. MoCa assesses seven areas of cognition for a total possible score of 30 points. A score of 25 or less is indicative of cognitive impairment.
ClinicalTrials.gov
PrimaryTo compare performance on neuropsychological battery between active and sham tDCS groupsthree months
To compare performance on neuropsychological battery (Brief Visuospatial Memory Test, Stroop color test, Stroop color-word test, Trail Making Test-Part A and Part B, Verbal Learning Memory Test, Wisconsin Card Sorting Test, Weschler Memory Scale) between active and sham tDCS groups. To assess global cognition at each time point, we calculated a composite score by averaging the Z scores from these outcome measures. The mean and SD of the baseline scores were used to calculate Z scores both at baseline and at follow up time points.
ClinicalTrials.gov
SecondaryTo compare Electrophysiological improvement on P300 between active and sham tDCS groupsthree monthsincrease P300 amplitude from the seventh stimulus onwards \*p\>0.05ClinicalTrials.gov
OtherGlobal improvement or response to treatmentsix monthsremain the same or have increased 1 point on the Clinical Global Impression Scale. The higher the score, the better the overall performance.ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 4

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
31455860BACKGROUNDPubMed
31938757BACKGROUNDPubMed
33070785BACKGROUNDPubMed
38765850BACKGROUNDPubMed

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 3

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Card Sorting Test (Berg)Primary outcomeConductCognition
Stroop Color-Word TestPrimary outcomeConductCognition
Trail Making Test APrimary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)